OliPass Corporation | Ace Dongbaek Tower 20th Floor, 16-4, 16 Beon-gil, Dongbaek Jungang-ro, Giheung-gu, Yongin, Gyeonggi 17015 Republic of Korea

  • we create
    breakthru medicines

    Technology revolutionizes our views of life sciences and brings us great quality of life

    we create
    breakthru
    medicines

    Technology revolutionizes our views
    of life sciences and
    brings us great quality of life

  • we create
    breakthru medicines

    Technology revolutionizes our views of life sciences and brings us great quality of life

    we create
    breakthru
    medicines

    Technology revolutionizes our views
    of life sciences and
    brings us great quality of life

  • we create
    breakthru medicines

    Technology revolutionizes our views of life sciences and brings us great quality of life

    we create
    breakthru
    medicines

    Technology revolutionizes our views
    of life sciences and
    brings us great quality of life

  • we create
    breakthru medicines

    Technology revolutionizes our views of life sciences and brings us great quality of life

    we create
    breakthru
    medicines

    Technology revolutionizes our views
    of life sciences and
    brings us great quality of life

  • we create
    breakthru medicines

    Technology revolutionizes our views of life sciences and brings us great quality of life

    we create
    breakthru
    medicines

    Technology revolutionizes our views
    of life sciences and
    brings us great quality of life

이전
ON/OFF
다음

OUR
TECHNOLOGY

OliPass PNA(OPNA)페이지 바로가기

OliPass Peptide Nucleic Acid (OliPass PNA) is derived from PNA by rationally introducing cationic lipid moiety onto nucleobase. By covalently attaching such cationic lipid groups onto PNA, the cell permeability markedly improved - thus a platform technology optimized for exon skipping inside the cell nucleus. OliPass Peptide Nucleic Acid (OliPass PNA) is derived from PNA by rationally introducing cationic lipid moiety onto nucleobase.

페이지 바로가기
Exon Skipping페이지 바로가기

Since OliPass PNA (OPNA) specifically binds to the target region of the pre-mRNA to induce exon skipping, multiple new drug candidates can be discovered and it can be developed as a safe and efficacious therapeutic. Since OliPass PNA (OPNA) specifically binds to the target region of the pre-mRNA to induce exon skipping, multiple new drug candidates can be discovered and it can be developed as a safe and efficacious therapeutic.

페이지 바로가기
Pipeline페이지 바로가기

Global #1 R&D Biotech Company in RNA therapeutics is our company vision. Global #1 R&D Biotech Company in RNA therapeutics is our company vision.

페이지 바로가기